Publications:

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research

Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H

Publication Date: 2022-01

Variant appearance in text: APC: L234Q

PubMed Link: 34963661

Variant Present in the following documents:

• supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3

View BVdb publication page

Fc-engineered antibodies with immune effector functions completely abolished.

Plos One

Wilkinson, Ian I; Anderson, Stephen S; Fry, Jeremy J; Julien, Louis Alex LA; Neville, David D; Qureshi, Omar O; Watts, Gary G; Hale, Geoff G

Publication Date: 2021

Variant appearance in text: APC: L234Q

PubMed Link: 34932587

Variant Present in the following documents:

• Main text
• pone.0260954.pdf

View BVdb publication page

Fc-engineered antibodies with immune effector functions completely abolished.

Plos One

Wilkinson, Ian I; Anderson, Stephen S; Fry, Jeremy J; Julien, Louis Alex LA; Neville, David D; Qureshi, Omar O; Watts, Gary G; Hale, Geoff G

Publication Date: 2021

Variant appearance in text: APC: L234Q

PubMed Link: 34932587

Variant Present in the following documents:

• Main text
• pone.0260954.pdf

View BVdb publication page

Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.

Genome Medicine

Bao, Riyue R; Stapor, Daniel D; Luke, Jason J JJ

Publication Date: 2020-10-27

Variant appearance in text: APC: L234Q

PubMed Link: 33106165

Variant Present in the following documents:

• 13073_2020_787_MOESM1_ESM.xlsx, sheet 9

View BVdb publication page